The use of cefepime (BMY 28142) to treat respiratory infections
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (3) , 257-260
- https://doi.org/10.1016/0732-8893(89)90023-0
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- β-Lactam Antibiotics: Structural Relationships Affecting in Vitro Activity and Pharmacologic PropertiesClinical Infectious Diseases, 1986
- Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacyAntimicrobial Agents and Chemotherapy, 1986
- The activity of BMY 28142 a new broad spectrum β-lactamase stable cephalosporinJournal of Antimicrobial Chemotherapy, 1986
- Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporinAntimicrobial Agents and Chemotherapy, 1985
- In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1985
- HR 810 and BMY-28142, two new cephalosporins with broad-spectrum activity:an in-vitro comparison with other β-lactam antibioticsJournal of Antimicrobial Chemotherapy, 1985